Selechimica

Acquired By IMCD
API manufacturing is specialized in by Selechimica as a CDMO.

About Selechimica

Selechimica is a Healthcare company, and was acquired by IMCD in June 2024. API manufacturing is specialized in by Selechimica as a CDMO. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.

Company details

Selechimica is operated as a contract development and manufacturing organization in the pharmaceutical industry. Active pharmaceutical ingredients are produced through focused manufacturing processes. Services encompass contract development alongside production for various clients. Ownership is held by Luca Pesce. Emphasis is placed on compliance with industry standards, though specific geographic operations remain unspecified. The companys domain is listed as selechimica.tcc.mode for further reference.

  • Stage Acquired
  • Sectors
    Healthcare
  • Acquired by IMCD (Jun 2024)
Key Metrics

Investors in Selechimica

Selechimica has secured backing from 1 investor. Prominent investors backing the company include IMCD.

All
InvestorDescriptionFounded YearDomainLocation
Speciality chemicals and food ingredients are distributed by IMCD.
1995imcdgroup.comRotterdam, Netherlands
Premium access

Investor details for Selechimica

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Selechimica

1 people are tracked at Selechimica (1 in leadership).

NameRoleGroup
Luca Pesce
OwnerLeadership
Premium access

Complete people profiles for Selechimica

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Selechimica

Selechimica is operated as a contract development and manufacturing organization in the pharmaceutical industry. Active pharmaceutical ingredients are produced through focused manufacturing processes. Services encompass contract development alongside production for various clients. Ownership is held by Luca Pesce. Emphasis is placed on compliance with industry standards, though specific geographic operations remain unspecified. The companys domain is listed as selechimica.tcc.mode for further reference.

Selechimica has 1 investor. Key investors include IMCD.

Yes. Selechimica was acquired by IMCD in June 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available